Overview

Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether clonazepam is effective and safe in the treatment of rapid eye movement behavior disorder (RBD) of patients with Parkinson's disease (PD).
Phase:
Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
Ministry of Food and Drug Safety, Korea
Treatments:
Clonazepam